These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21252288)

  • 1. Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework.
    Huang YB; Wang XF; Wang HY; Liu Y; Chen Y
    Mol Cancer Ther; 2011 Mar; 10(3):416-26. PubMed ID: 21252288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.
    Chen Y; Guarnieri MT; Vasil AI; Vasil ML; Mant CT; Hodges RS
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1398-406. PubMed ID: 17158938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of helicity on the anticancer mechanism of action of cationic-helical peptides.
    Huang YB; He LY; Jiang HY; Chen YX
    Int J Mol Sci; 2012; 13(6):6849-6862. PubMed ID: 22837667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.
    Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR
    Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan as a probe to study the anticancer mechanism of action and specificity of α-helical anticancer peptides.
    Li G; Huang Y; Feng Q; Chen Y
    Molecules; 2014 Aug; 19(8):12224-41. PubMed ID: 25123187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The study of single anticancer peptides interacting with HeLa cell membranes by single molecule force spectroscopy.
    Shan Y; Huang J; Tan J; Gao G; Liu S; Wang H; Chen Y
    Nanoscale; 2012 Feb; 4(4):1283-6. PubMed ID: 22215262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomeric Effect of d-Amino Acid Substitution on the Mechanism of Action of α-Helical Membrane-Active Peptides.
    Sun S; Zhao G; Huang Y; Cai M; Yan Q; Wang H; Chen Y
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally designed short cationic α-helical peptides with selective anticancer activity.
    Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
    J Colloid Interface Sci; 2022 Feb; 607(Pt 1):488-501. PubMed ID: 34509120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.
    Yang QZ; Wang C; Lang L; Zhou Y; Wang H; Shang DJ
    Arch Pharm Res; 2013 Nov; 36(11):1302-10. PubMed ID: 23609760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity.
    Chen C; Yang C; Chen Y; Wang F; Mu Q; Zhang J; Li Z; Pan F; Xu H; Lu JR
    ACS Appl Mater Interfaces; 2016 Oct; 8(40):26501-26510. PubMed ID: 27644109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of highly charged (+5 to +10) amphipathic α-helical peptide standards by cation-exchange and reversed-phase high-performance liquid chromatography.
    Mant CT; Byars A; Ankarlo S; Jiang Z; Hodges RS
    J Chromatogr A; 2018 Nov; 1574():60-70. PubMed ID: 30220427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.
    Kiyota T; Lee S; Sugihara G
    Biochemistry; 1996 Oct; 35(40):13196-204. PubMed ID: 8855958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane segment peptides with double D-amino acid replacements: helicity, hydrophobicity, and antimicrobial activity.
    Maeda M; Melnyk RA; Partridge AW; Liu LP; Deber CM
    Biopolymers; 2003; 71(1):77-84. PubMed ID: 12712502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Anticancer Activity of Site Specific Short Chain Cationic Peptide.
    Sharma RD; Jain J; Khosa RL
    Curr Drug Discov Technol; 2020; 17(5):631-646. PubMed ID: 30947673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From a pro-apoptotic peptide to a lytic peptide: One single residue mutation.
    Zhou XR; Zhang Q; Tian XB; Cao YM; Liu ZQ; Fan R; Ding XF; Zhu Z; Chen L; Luo SZ
    Biochim Biophys Acta; 2016 Aug; 1858(8):1914-25. PubMed ID: 27207743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the minimum hydrophobicity of alpha-helical peptides required to maintain a stable transmembrane association with phospholipid bilayer membranes.
    Lewis RN; Liu F; Krivanek R; Rybar P; Hianik T; Flach CR; Mendelsohn R; Chen Y; Mant CT; Hodges RS; McElhaney RN
    Biochemistry; 2007 Jan; 46(4):1042-54. PubMed ID: 17240988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S.
    Lee DL; Powers JP; Pflegerl K; Vasil ML; Hancock RE; Hodges RS
    J Pept Res; 2004 Feb; 63(2):69-84. PubMed ID: 15009528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the selectivity and efficacy of defense peptides with respect to cancer cells.
    Harris F; Dennison SR; Singh J; Phoenix DA
    Med Res Rev; 2013 Jan; 33(1):190-234. PubMed ID: 21922503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells.
    Sang M; Zhang J; Zhuge Q
    Eur J Pharmacol; 2017 May; 803():138-147. PubMed ID: 28347740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.